288 related articles for article (PubMed ID: 33081658)
21. Cardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition.
Embry-Dierson M; Farrell MB; Schockling E; Warren J; Jerome S
J Nucl Med Technol; 2023 Jun; 51(2):83-89. PubMed ID: 37268319
[TBL] [Abstract][Full Text] [Related]
22. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
23. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
[TBL] [Abstract][Full Text] [Related]
24. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M
Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926
[TBL] [Abstract][Full Text] [Related]
25. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
26. Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?
Algalarrondo V; Piekarski E; Eliahou L; Le Guludec D; Slama MS; Rouzet F
Curr Cardiol Rep; 2018 Mar; 20(5):33. PubMed ID: 29574587
[TBL] [Abstract][Full Text] [Related]
27. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
Brownrigg J; Lorenzini M; Lumley M; Elliott P
ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
[TBL] [Abstract][Full Text] [Related]
29. Nuclear Imaging for Cardiac Amyloidosis: Bone Scan, SPECT/CT, and Amyloid-Targeting PET.
Paeng JC; Choi JY
Nucl Med Mol Imaging; 2021 Apr; 55(2):61-70. PubMed ID: 33968272
[TBL] [Abstract][Full Text] [Related]
30. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
31.
Papathanasiou M; Kessler L; Carpinteiro A; Hagenacker T; Nensa F; Umutlu L; Forsting M; Brainman A; Kleinschnitz C; Antoch G; Dührsen U; Schlosser TW; Herrmann K; Rassaf T; Luedike P; Rischpler C
J Nucl Cardiol; 2022 Apr; 29(2):779-789. PubMed ID: 33025472
[TBL] [Abstract][Full Text] [Related]
32. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis.
Lioncino M; Monda E; Palmiero G; Caiazza M; Vetrano E; Rubino M; Esposito A; Salerno G; Dongiglio F; D'Onofrio B; Verrillo F; Cerciello G; Manganelli F; Pacileo G; Bossone E; Golino P; Calabrò P; Limongelli G
Heart Fail Clin; 2022 Jan; 18(1):73-87. PubMed ID: 34776085
[TBL] [Abstract][Full Text] [Related]
34. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
35. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
36. The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy.
Itzhaki Ben Zadok O; Ruhrman-Sahar N; Mats I; Vaxman I; Shiyovich A; Aviv Y; Vaturi M; Wiessman M; Shochat T; Kandinov I; Kornowski R; Hamdan A
ESC Heart Fail; 2023 Jun; 10(3):1666-1676. PubMed ID: 36799266
[TBL] [Abstract][Full Text] [Related]
37. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
38. Value of nuclide scintigraphy in the diagnosis and prognosis of cardiac amyloidosis.
Mo Q; Deng Z; Xiao Y; Liu C; Zhao M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1739-1745. PubMed ID: 38432865
[TBL] [Abstract][Full Text] [Related]
39. Clinical Application of
Shoura S; Malhotra S
J Nucl Med Technol; 2023 Jun; 51(2):125-128. PubMed ID: 37268320
[TBL] [Abstract][Full Text] [Related]
40. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
Rauf MU; Hawkins PN; Cappelli F; Perfetto F; Zampieri M; Argiro A; Petrie A; Law S; Porcari A; Razvi Y; Bomsztyk J; Ravichandran S; Ioannou A; Patel R; Starr N; Hutt DF; Mahmood S; Wisniowski B; Martinez-Naharro A; Venneri L; Whelan C; Roczenio D; Gilbertson J; Lachmann HJ; Wechalekar AD; Rapezzi C; Serenelli M; Massa P; Caponetti AG; Ponziani A; Accietto A; Giovannetti A; Saturi G; Sguazzotti M; Gagliardi C; Biagini E; Longhi S; Fontana M; Gillmore JD
Eur Heart J; 2023 Jun; 44(24):2187-2198. PubMed ID: 36946431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
